Effect of wood smoke exposure on vascular function and thrombus formation in healthy fire fighters by Hunter, Amanda L et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of wood smoke exposure on vascular function and
thrombus formation in healthy fire fighters
Citation for published version:
Hunter, AL, Unosson, J, Bosson, JA, Langrish, JP, Pourazar, J, Raftis, JB, Miller, MR, Lucking, AJ, Boman,
C, Nyström, R, Donaldson, K, Flapan, AD, Shah, A, Pung, L, Sadiktsis, I, Masala, S, Westerholm, R,
Sandström, T, Blomberg, A, Newby, DE & Mills, NL 2014, 'Effect of wood smoke exposure on vascular
function and thrombus formation in healthy fire fighters' Particle and Fibre Toxicology, vol. 11, no. 1, 62.
DOI: 10.1186/s12989-014-0062-4
Digital Object Identifier (DOI):
10.1186/s12989-014-0062-4
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Particle and Fibre Toxicology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Hunter et al. Particle and Fibre Toxicology  (2014) 11:62 
DOI 10.1186/s12989-014-0062-4RESEARCH Open AccessEffect of wood smoke exposure on vascular
function and thrombus formation in healthy fire
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Anoop SV Shah1, Louis Pung1, Ioannis Sadiktsis6, Silvia Masala6, Roger Westerholm6, Thomas Sandström2,
Anders Blomberg2, David E Newby1 and Nicholas L Mills1*Abstract
Background: Myocardial infarction is the leading cause of death in fire fighters and has been linked with exposure
to air pollution and fire suppression duties. We therefore investigated the effects of wood smoke exposure on
vascular vasomotor and fibrinolytic function, and thrombus formation in healthy fire fighters.
Methods: In a double-blind randomized cross-over study, 16 healthy male fire fighters were exposed to wood
smoke (~1 mg/m3 particulate matter concentration) or filtered air for one hour during intermittent exercise. Arterial
pressure and stiffness were measured before and immediately after exposure, and forearm blood flow was measured
during intra-brachial infusion of endothelium-dependent and -independent vasodilators 4–6 hours after exposure.
Thrombus formation was assessed using the ex vivo Badimon chamber at 2 hours, and platelet activation was
measured using flow cytometry for up to 24 hours after the exposure.
Results: Compared to filtered air, exposure to wood smoke increased blood carboxyhaemoglobin concentrations
(1.3% versus 0.8%; P < 0.001), but had no effect on arterial pressure, augmentation index or pulse wave velocity (P > 0.05
for all). Whilst there was a dose-dependent increase in forearm blood flow with each vasodilator (P < 0.01 for all), there
were no differences in blood flow responses to acetylcholine, sodium nitroprusside or verapamil between exposures
(P > 0.05 for all). Following exposure to wood smoke, vasodilatation to bradykinin increased (P = 0.003), but there was
no effect on bradykinin-induced tissue-plasminogen activator release, thrombus area or markers of platelet activation
(P > 0.05 for all).
Conclusions: Wood smoke exposure does not impair vascular vasomotor or fibrinolytic function, or increase thrombus
formation in fire fighters. Acute cardiovascular events following fire suppression may be precipitated by exposure to
other air pollutants or through other mechanisms, such as strenuous physical exertion and dehydration.
Trial registration: ClinicalTrials.gov Identifier: NCT01495325.
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Cardiovascular events are the leading cause of occupa-
tional death amongst fire fighters and account for ap-
proximately 45% of fatalities per year [1]. Moreover, the
risk of acute myocardial infarction is increased 12- to
136-fold during fire suppression duties as compared to
non-emergency duties and is likely to reflect a combin-
ation of factors including extreme physical exertion,
mental stress, and exposure to heat and air pollutants
[2]. Firefighters, during active fire suppression, are usu-
ally protected from smoke exposure by self-contained
breathing apparatus (SCBA), however this is often disre-
garded in potentially hazardous, but tolerable situations,
such as wildland fires where the long duration and remote
location of fire fighting often renders SCBA wearing im-
practical [3]. Respiratory protection, therefore, often takes
the form of a cotton rag or bandana tied around the nose
and mouth.
Air pollution is an established risk factor for the devel-
opment of both acute and chronic cardiovascular diseases
[4-11] with exposure to particulate matter (PM) consist-
ently associated with adverse cardiovascular health effects.
The mechanisms through which specific air pollutants,
and in particular traffic-derived air pollutants, influence
the cardiovascular system have been intensively studied
and an understanding of their effects on the pathophysi-
ology of disease is emerging. In contrast, the health effects
of wood smoke and biomass exposure have received little
attention. Wood smoke contributes large quantities of ul-
trafine particles to our environment through the combus-
tion of biomass for heating and cooking, and during
major wildland fires. Firefighters have significant and often
prolonged exposures during wildland fire fighting, an im-
portant duty of the fire service.
We have previously demonstrated that exposure to
diesel exhaust impairs endothelial vasomotor and fibrino-
lytic function and increased ex-vivo thrombosis in man
[12,13]. We have also demonstrated that exposure to
wood smoke causes transient increases in arterial stiffness
in healthy volunteers [14]. We therefore hypothesised that
exposure to wood smoke, rich in ultrafine particulate mat-
ter, would have similar adverse effects and may explain
the association between fire suppression and excess
cardiovascular death. We therefore assessed the effect
of exposure to wood smoke on vascular vasomotor and
fibrinolytic function, and thrombus formation in healthy
fire fighters.
Results
Exposures were well tolerated with no adverse symp-
toms reported and all subjects completed both study
visits.
Within the chamber, particulate matter with an aero-
dynamic diameter <1 μm (PM1) concentrations were1,115 ± 151 μg/m3, with nitrogen oxides (NOx) and car-
bon monoxide (CO) concentrations of 0.6 ± 0.1 ppm and
16.0 ± 1.1 ppm respectively (Table 1; Figure 1). Total PM
mass was consistent with the target concentration for
the study, as shown by both TEOM and filter measure-
ments. The high EC/TC ratio illustrates the high soot
content in wood smoke. The total PAH concentration in
the exposure chamber was 4.3 ± 2.5 μg/m3, of which
90% was associated with wood smoke PM. The concen-
tration of PM associated benzo[a]pyrene was 443 ±
302 ng/m3. The most abundant PAH compounds in the
wood smoke PM fraction, accounting for 88 ± 1% of the
total analyzed PAH (both PM associated and gas phase),
were (in descending order): benzo[a]pyrene, chrysene,
benzo[b]fluoranthene, benz[a]anthracene, benzo[e]pyr-
ene, benzo[ghi]perylene, benzo[ghi]fluoranthene, indeno
[1,2,3-cd]pyrene, pyrene, fluoranthene, benzo[k]fluoran-
thene and coronene (Additional file 1: Table S1).
The mean primary particle size was 168 nm and the
number size distribution (mobility diameter) was clearly
bi-modal with a lower peak around 50–80 nm and an
upper peak around 150–200 nm (Figure 2). Wood smoke
particulate generated superoxide free radicals in physio-
logical saline solutions in the absence of cells or tissue.
Comparing equivalent masses of particulate, the super-
oxide generating capacity of wood smoke particulates was
greater than standard reference material urban dust or
pyrogallol controls (P < 0.001) (Figure 2).Haematology
Blood carboxyhaemoglobin concentrations increased
from 0.9 ± 0.04 to 1.3 ± 0.04% immediately following ex-
posure to wood smoke (P < 0.001) (Table 2). Total leuco-
cyte, lymphocyte, neutrophil and platelet counts, were
unaffected for up to 24 h after the exposure.Arterial stiffness and vascular function
Resting blood pressure and heart rate were unchanged
during either exposure or for up to 24 h after exposure
(Table 3). Augmentation index, augmentation pressure
and pulse wave velocity increased immediately after ex-
posure (P > 0.05), but changes were similar following ex-
posure to wood smoke and filtered air (P > 0.05 for all
comparisons of wood smoke versus filtered air).
There was a dose-dependent increase in forearm blood
flow with each vasodilator (P < 0.01 for all). However
there were no differences in blood flow responses to
acetylcholine (P = 0.91), sodium nitroprusside (P = 0.52)
or verapamil (P = 0.63) between exposures (Figure 3). In
contrast, there was an increase in forearm blood flow with
bradykinin infusion following exposure to wood smoke
compared to filtered air (P = 0.003). Bradykinin caused a
dose-dependent release of tissue plasminogen activator
Table 1 Characterization of wood smoke exposure and particulate matter
n Unit Mean SD Min Max
PM1 mass concentration (TEOM) 16 μg/m
3 1,115 151 922 1,561
PM1 mass concentration (filter) 16 μg/m
3 899 100 726 1,105
Carbon monoxide 16 ppm 16 6 8 25
Nitrogen oxides 16 ppm 0.6 0.3 0.3 1.0
Elemental carbon/total carbon1 6 ratio 0.80 0.02 0.79 0.83
Organic fraction of total PM1,2 6 % 23.1 4.7 16.9 28.8
Soot fraction of total PM1 6 % 60.1 15.7 39.9 78.8
PAH – PM associated (filter)1,3 6 μg/m3 3.9 2.3 1.5 6.7
PAH – semi-volatile (PUF)1,3 6 μg/m3 0.4 0.3 0.1 0.9
1OC-EC and PAH analysis from selected samples throughout the campaign (n = 6).
2Estimated based on the OC-EC analysis (assuming a factor of 1.8 used to covert OC to total organic PM and a factor of 1.1 used to convert EC to total soot PM).
3Includes the PAHs: phenanthrene, anthracene, 4H-cyclopenta[def]phenanthrene, 2-phenylnaphthalene, fluoranthene, pyrene, 1-methylfluoranthene, benz[a]fluorene,
benz[b]fluorene, 2-methylpyrene, 4-methylpyrene, 1-methylpyrene, benzo[c]phenanthrene, benzo[ghi]fluoranthene, benzo[b]naphtho[1,2-d]thiophene, benz[a]
anthracene, chrysene, 3-methylchrysene, 2-methylchrysene, 6-methylchrysene, 1-methylchrysene, benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[e]pyrene,
benzo[a]pyrene, perylene, indeno[1,2,3-cd]fluoranthene, indeno[1,2,3-cd]pyrene, dibenz[a,h]anthracene, picene, benzo[ghi]perylene, dibenzo[a,l]pyrene, dibenzo
[a,e]pyrene, coronene, dibenzo[a,i]pyrene and dibenzo[a,h]pyrene.
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(P = 0.72) (Figure 4).
Platelet activation and thrombosis
Platelet-monocyte binding, monocyte surface expression
of CD40 and platelet surface expression of CD40L andFigure 1 Particulate matter concentration during exposures.
(a) A typical time-series of particle mass concentrations (PM1) in the
chamber during a single 1 hour exposure measured with TEOM with
data points every 30 seconds. (b) Average mass concentrations
(PM1) in the chamber during the 1 hour exposures measured with
TEOM (n = 16) every 30 seconds (mean ± standard deviation).P-selectin were similar following wood smoke and filtered
air exposure at 2 and 24 h following exposure (P > 0.05 for
all) (Figure 4). There was no difference in thrombus for-
mation following exposure to wood smoke compared with
filtered air (thrombus area 12,216 ± 3,237 versus 12,775 ±
3,831 μm2, P = 0.54) (Figure 4).
Discussion
Controlled exposure to wood smoke at high particulate
concentrations does not impair endothelial-dependent
or -independent vasodilation or increase thrombosis in
firefighters. Using established methodology and a com-
prehensive assessment of cardiovascular health we found
no adverse effects of wood smoke to explain the cardio-
vascular risk associated with fire suppression duties.
Whilst there have been no prior controlled exposures
to wood smoke in firefighters, the effect of wood smoke
on vascular function has been studied in healthy volunteers
[17] and systemic inflammatory effects have been observed
in firefighters responding to forest fires [18-20]. We have
previously demonstrated that exposure to wood smoke for
3 hours at a lower PM concentration of 300 μg/m3 caused
a transient increases in arterial stiffness and heart rate
[14]. In contrast, we found no effect on arterial stiffness or
heart rate following exposure to wood smoke at three-fold
higher concentrations in firefighters over one hour. The
overall dose was similar in both studies. These discordant
findings may be explained by differences in susceptibility
to wood smoke between healthy volunteers and fire-
fighters with the latter having had multiple previous expo-
sures to wood smoke through their occupation. There is
some evidence that repeated exposure to smoke upre-
gulates anti-oxidant levels in the airways and may di-
minish the effects of an acute exposure [21]. However
we restricted enrollment to those firefighters who had
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Figure 2 Characterization of wood smoke particulate matter. (a) Scanning electron microscopy (SEM) image of wood smoke particles.
(b) Size distribution graph of the particle size as assessed by photon correlation spectroscopy with the mean primary particle size
indicated by the red line. (c) Average particle number size distribution in the exposure chamber, measured by SMPS system. The plot
displays the distribution as mean and standard deviation from all 16 exposures. Previous studies demonstrate the 50–80 nm peak consists
of alkali salt particles (e.g. potassium sulphate and potassium chloride) and the 150–200 nm peak soot particles with more organic material
[15,16]. (d) Electron paramagnetic resonance (EPR) signal intensity showing oxygen free radical generation from wood smoke particulates in the
presence of the superoxide-selective spin-trap Tempone-H. Particulates from exposures collected on Teflon filters suspended in physiological
saline solution at a concentration of 100 μg particles/mL. The standard reference material urban dust (100 μg particles/mL) and pyrogallol (100 μM)
were used as controls. Data expressed as mean ± SEM (n = 4–5).
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than one week prior to study visits and the effects of pre-
vious exposure on anti-oxidant levels are likely to be tran-
sient. It is also interesting to note that the baseline heart
rates in our previous study [14] were approximately
10 bpm higher than in this study, perhaps suggesting pre-
vious participants were more susceptible to any effects of
exposure on the autonomic nervous system. The duration
of exposure may also be important with effects of wood
smoke on arterial tone emerging after longer expos-
ure periods. However, Forchhammer et al. recently ob-
served no effect of wood smoke on peripheral arterial
tone assessed by finger plethysmography despite deliver-
ing PM at 350 μg/m3 for up to 3 hours [17].Venous occlusion plethysmography with intra-arterial
infusion of vasodilators is widely regarded as the ‘gold-
standard’ assessment of vascular function. We found no
detrimental effect of exposure to wood smoke or filtered air
on either endothelium-dependent or -independent vaso-
dilatation. In fact we demonstrate a small increase in blood
flow in response to bradykinin infusion following wood
smoke exposure. It is plausible this was due to the effects
of carbon monoxide exposure at concentrations that were
sufficient to increase carboxyhaemoglobin concentrations
and indeed, carbon monoxide is emerging as an important
mediator of the vasodilator effects of bradykinin in the
vessel wall [22]. The levels of carbon monoxide in this
study were 4-fold higher than previous exposures to dilute
Table 2 Haematological effects of exposure to wood smoke and filtered air
Filtered air Wood smoke P value1
Carboxyhaemoglobin, % Baseline 0.9 ± 0.0 0.9 ± 0.0 <0.001
2 hours 0.8 ± 0.0 1.3 ± 0.0*
24 hours 0.8 ± 0.0 0.8 ± 0.0
Leucocytes × 109 cells/L Baseline 5.5 ± 0.4 5.6 ± 0.4 0.22
2 hours 6.1 ± 0.3 6.4 ± 0.4
6 hours 6.5 ± 0.3 6.9 ± 0.4
24 hours 5.4 ± 0.3 5.6 ± 0.4
Lymphocytes × 109 cells/L Baseline 2.0 ± 0.2 2.0 ± 0.2 0.11
2 hours 1.9 ± 0.1 1.8 ± 0.1
6 hours 2.0 ± 0.1 2.1 ± 0.1
24 hours 2.0 ± 0.2 2.0 ± 0.2
Neutrophils × 109 cells/L** Baseline 2.8 ± 0.3 2.9 ± 0.3 0.20
2 hours 3.6 ± 0.3 3.9 ± 0.4
6 hours 3.8 ± 0.3 4.1 ± 0.3
24 hours 2.8 ± 0.2 3.0 ± 0.3
Platelets × 109 cells/L** Baseline 225 ± 6 229 ± 7 0.07
2 hours 212 ± 6 219 ± 7
6 hours 205 ± 5 203 ± 9
24 hours 225 ± 7 234 ± 6
Values are reported as mean ± SEM.
12-way ANOVA with repeated measures comparing filtered air and wood smoke exposures.
*P <0.001 following Bonferroni correction comparing filtered air and wood smoke.at a given time point.
**P < 0.05 for trend across time.
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dilation as a consequence of higher gaseous pollutants
(carbon monoxide or nitrogen oxides [24]), may be im-
portant here. Nevertheless, it is unlikely that this would
offset any detrimental effects of wood smoke PM on fore-
arm blood flow across other vasodilators. There were no
other important or adverse effects of wood smoke on vas-
cular function, including endogenous fibrinolysis, platelet
activation and thrombosis. Taken together these findings
suggest that exposure to wood smoke is unlikely to be the
primary cause of acute adverse cardiovascular events in
firefighters.
Whilst traffic-related air pollution is an established trig-
ger for acute myocardial infarction [4,6,9,25], there are
few studies that have linked exposure to wood smoke or
biomass with cardiovascular events. The risk in firefighters
may be mediated by other factors, such as exposure to
extreme heat, physical exertion and psychological stress.
Heat stress results from both high ambient temperatures
and exercise-induced metabolic activity, exacerbated by
insulated protective clothing. In controlled studies, heat
stress causes vasodilatation and fluid loss, resulting in a
reduction in cardiac output and a hypercoagulable state
[26-29]. Strenuous physical exertion is an independent
trigger of sudden cardiovascular events, particularly in in-
dividuals unaccustomed to exercise [30]. Fire suppressionoften requires firefighters to work at the extremes of phys-
ical capability associated with heart rates in excess of age
predicted maximums [26,27,31-33] and for long periods
with shifts frequently lasting 12 to 24 h [34]. Whilst ex-
posure to wood smoke may not in isolation cause vascular
dysfunction or induce a prothrombotic state, it remains
plausible that firefighters responding to wildland fires are
at increased risk of an acute cardiovascular event through
a combination of factors that could still include wood
smoke. Furthermore, firefighters are also exposed to a
heterogenous mix of air pollutants during other activities
and although the use of breathing apparatus is employed
in these situations, at the perimeter of such fires and in
the aftermath when, breathing apparatus is removed im-
portant exposures may occur.
It is perhaps surprising that exposure to fine wood
smoke particles at concentrations in excess of 1,000 μg/m3
had no adverse effects given that exposure to diesel ex-
haust at 300 μg/m3 has previously been shown to impair
vascular function and increase thrombus formation in
healthy men [12,13,35]. Differences in particle properties
such as size, composition and surface chemistry between
these exposures are likely to be important. Although the
majority of wood smoke and diesel exhaust particles are in
the ultrafine size fraction, the diameter of primary wood
smoke particles was 5-fold larger than diesel exhaust
Table 3 Haemodynamic effects of exposure to wood smoke and filtered air
Baseline Post-exposure
0 mins 10 mins 20 mins 30 mins 40 mins 50 mins 1 hr 2 hrs 6 hrs 24 hr mean P-value1
Systolic pressure, mmHg Filtered air 135 ± 2 134 ± 2 133 ± 2 130 ± 3 131 ± 2 131 ± 2 130 ± 3 133 ± 2 132 ± 2 130 ± 2 124 ± 2 0.59
Wood smoke 132 ± 2 135 ± 3 131 ± 3 130 ± 3 131 ± 3 130 ± 3 130 ± 3 135 ± 4 134 ± 5 131 ± 3 127 ± 2
Diastolic pressure, mmHg Filtered air 75 ± 2 74 ± 3 75 ± 2 75 ± 2 73 ± 4 76 ± 2 76 ± 2 76 ± 2 76 ± 2 76 ± 27 68 ± 2 0.89
Wood smoke 75 ± 2 74 ± 2 74 ± 2 73 ± 2 74 ± 2 74 ± 2 76 ± 2 77 ± 2 77 ± 2 75 ± 2 70 ± 2
Heart rate, bpm Filtered air 63 ± 2 63 ± 3 63 ± 3 61 ± 3 60 ± 2 59 ± 2 59 ± 2 58 ± 2 58 ± 2 59 ± 2 56 ± 2 0.12
Wood
smoke
61 ± 3 63 ± 3 63 ± 3 62 ± 3 62 ± 3 61 ± 3 61 ± 3 60 ± 3 60 ± 3 58 ± 3 55 ± 2
Δ Augmentation
pressure, mmHg
Filtered air - 0.2 ± 0.5 −0.4 ± 0.7 −0.7 ± 0.6 −0.1 ± 0.7 −0.2 ± 0.7 0.1 ± 0.7 0.7 ± 0.7 - - - 0.90
Wood smoke - 1.0 ± 0.8 −0.2 ± 0.3 −0.5 ± 0.3 −0.7 ± 0.4 −0.3 ± 0.5 0.6 ± 0.5 0.2 ± 0.5 - - -
Δ Augmentation
index @75 bpm, %
Filtered air - 0.01 ± 4.6 −1.7 ± 6.7 −3.9 ± 6.1 −2.8 ± 7.6 −3.0 ± 7.5 −2.2 ± 7.0 −1.2 ± 7.2 - - - 0.72
Wood smoke - 2.3 ± 7.6 −1.1 ± 4.0 - 2.0 ± 5.1 −3.2 ± 5.0 −3.0 ± 6.4 −1.3 ± 6.7 −1.6 ± 6.0 - - -
Δ Pulse wave
velocity, m/s
Filtered air - 0.1 ± 0.1 0.0 ± 0.1 0.1 ± 0.1 0.0 ± 0.1 −0.1 ± 0.1 0.0 ± 0.1 0.4 ± 0.5 - - - 0.98
Wood smoke - 0.0 ± 0.1 −0.1 ± 0.1 0.0 ± 0.1 −0.1 ± 0.1 0.0 ± 0.1 −0.1 ± 0.1 0.1 ± 0.1 - - -
Values are reported as mean ± SEM.
12-way ANOVA with repeated measures comparing wood smoke and filtered air (baseline to 6 hrs); paired Students t-tests were performed for 24 hr means (P > 0.05 for all).
H
unter
et
al.Particle
and
Fibre
Toxicology
 (2014) 11:62 
Page
6
of
13
5 10 20
0
5
10
15
20
25
Acetylcholine µg/min
F
or
ea
rm
 B
lo
od
 F
lo
w
(m
l/1
00
m
l o
f t
is
su
e/
m
in
)
10
0
30
0
10
00
0
5
10
15
20
25
Filtered Air - Infused
Wood smoke - Infused
Filtered Air - Non-infused
Wood smoke - Non-infused
                Bradykinin pmol /min
F
or
ea
rm
 B
lo
od
 F
lo
w
(m
l/1
00
m
l o
f t
is
su
e/
m
in
)
2 4 8
0
5
10
15
20
25
Sodium Nitroprusside µg/min
F
or
ea
rm
 B
lo
od
 F
lo
w
(m
l/1
00
m
l o
f t
is
su
e/
m
in
)
10 30 10
0
0
5
10
15
20
25
Verapamil µg/min
F
or
ea
rm
 B
lo
od
 F
lo
w
(m
l/1
00
m
l o
f t
is
su
e/
m
in
)
Figure 3 Effect of wood smoke and filtered air on forearm blood flow. There was a dose-dependent increase in forearm blood flow with
each vasodilator (2-way ANOVA with repeated measures, P < 0.01 for all), however there were no differences in blood flow response to acetylcholine
(P = 0.91), sodium nitroprusside (P = 0.52) or verapamil (P = 0.63) between exposures. In contrast, there was an increase in the forearm blood flow to
bradykinin following exposure to wood smoke compared to filtered air (P = 0.003). All data expressed as mean ± SEM. There are no differences in blood
flow in the non-infused arms and therefore these data points are overlaid.
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material 2975 is 31 nm). Wood smoke particles are there-
fore perhaps less likely to deposit in terminal bronchioles
or alveolar space and therefore to translocate or deliver
soluble components into the circulation where they could
directly effect the cardiovascular system. If wood smoke
particles are unable to translocate due to larger size then
they could perhaps cause a systemic inflammatory re-
sponse, exerting late effects that were missed by undertak-
ing assessments early after exposure. Others have shown
that controlled exposure to fine and coarse PM is associ-
ated with early autonomic imbalance: rapid elevation of
blood pressure and heart rate, and decreased heart
rate variability immediately following exposure [36-39].
Conversely, we may have missed any immediate effects
mediated by autonomic imbalance that were not com-
prehensively assessed in this study, although blood pres-
sure and heart rate were unaffected acutely and over
the 24 hour study period. Differences in surface chemis-
try are also likely to be important. Whilst wood smoke
particles were able to generate super-oxide radicals, there
were major differences in the PAH profile between wood
smoke particles, where high molecular weight PAHs
(≥228 Da) dominated, as compared to diesel exhaust parti-
cles [40].There are some limitations to our study that merit
consideration. The time points chosen to conduct our
assessments post-exposure were based on the results of
previous studies [12-14,23,24,35,41-46]. However, it is
possible that wood smoke particles either exert an im-
mediate or late effect on the cardiovascular system and
we may have missed such effects. Additionally, the dur-
ation of exposure is also likely to be important with cu-
mulative exposures over many days or weeks difficult to
model experimentally. We recruited early career fire-
fighters to minimize potential for confounding due to
pre-existing vascular disease. Firefighters are exposed to
complex mixtures of air pollutants derived from differ-
ent sources, many of which may be more toxic than our
simulated wildland fire exposure. It is plausible that fire-
fighters with risk factors or subclinical disease would be
more susceptible to any adverse cardiovascular effects of
wood smoke. According to the widely recognized “healthy
worker effect” in occupational medicine, it is common
that susceptible individuals leave the workplace early due
to symptoms, discomfort or acute illness. This may lead to
selection bias with the remaining workers less sensitive or
resistant to these noxious factors. Furthermore, we pro-
spectively powered the study based on the measurements
of primary end points made during previous studies
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Figure 4 Effect of wood smoke and filtered air on platelet activation, fibrinolysis and thrombus formation ex vivo. (a) Platelet-monocyte
binding and (b) platelet expression of P-selectin were unchanged 2 and 24 hours following exposure to wood smoke or filtered air (ANOVA with
repeated measures, P > 0.05, n = 11–16). (c) Bradykinin caused a dose-dependent release of tissue-plasminogen activator (t-PA) antigen (2-way
ANOVA with repeated measures, P < 0.01), which was similar after both exposures (P > 0.05, n = 16). (d) Thrombus formation under high-sheer
conditions in the Badimon chamber was similar 2 hours after exposure to wood smoke or filtered air (Student’s t-test, P > 0.05, n = 13). All data
expressed as mean ± SEM.
Hunter et al. Particle and Fibre Toxicology  (2014) 11:62 Page 8 of 13[12,47-49]. Although we are confident that we have not
missed effects on endothelial function or ex vivo throm-
bosis, we acknowledge that we may have had insufficient
power to detect modest changes in some of the secondary
end points, and thus cannot exclude the possibility of false-
negative findings confounding their assessment. Neverthe-
less, even allowing for these limitations, in a carefully
designed and controlled study with a comprehensive as-
sessment of cardiovascular function, we found no adverse
effects of exposure to wood smoke.
Conclusions
Isolated wood smoke exposure at concentrations occur-
ring in the vicinity of major wildland fires did not impair
vascular vasomotor or fibrinolytic function, or increasethrombus formation in firefighters. The acute cardiovas-
cular events associated with fire suppression may not be
directly related to wood smoke exposure, rather they
may be precipitated by other pollutants or mechanisms
such as strenuous physical exertion and dehydration.
Methods
Subjects
Sixteen healthy non-smoking male volunteers (median
age 26, range 21–26 years) were enrolled into the study.
The study was performed with the approval of local
research Ethics Committees, in accordance with the
Declaration of Helsinki and the written informed con-
sent of all volunteers. Firefighters were recruited using ad-
vertisements in local fire stations. Exclusion criteria were
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the use of regular medication (specifically non-steroidal
anti-inflammatory drugs, vitamins or anti-oxidant supple-
ments), known ischemic heart disease, arrhythmia, dia-
betes mellitus, hypertension, renal or hepatic impairment,
asthma, or inter-current infection. Subjects had normal
lung function and reported no respiratory symptoms in
the 6-week period preceding the study. Subjects had no
occupational fire exposure (wildland or structural) for a
week preceding study visit.
Study design
Subjects attended on two occasions at least one week
apart and were exposed to filtered air or wood smoke
for one hour in a double-blind randomized crossover de-
sign. Subjects attended at 8 am on the morning of study
for initial bloods and for the fitting of Holter and ambula-
tory blood pressure monitors. Exposures were performed
at 10 am in a dedicated exposure facility by researchers
and technical staff not involved in the subsequent clinical
assessment. Subjects remained indoors following exposure
to minimize any confounding effects from ambient air
pollution. Vascular studies were carried out in a quiet,
temperature-controlled room maintained at 22°C to 24°C
with subjects lying supine. All subjects abstained from al-
cohol and caffeine for 24 h, and from food for at least 4 h
before each vascular study.
The primary endpoints were forearm blood flow, esti-
mated t-PA release from the forearm circulation and
ex-vivo thrombus formation. Secondary endpoints in-
cluded arterial stiffness, platelet activation, and changes
in haematological variables. Based on previous studies
[12-14,23,24,35,41-46], pulse wave analysis and velocity
were assessed immediately after exposure, a study of ex-
vivo thrombus formation, Badimon study was performed
at 2 h, and venous occlusion plethysmography undertaken
4 to 6 h after exposures to wood smoke and filtered air.
Venous blood was sampled at baseline, 2, 6 and 24 h after
each exposure for storage and quantification of carb-
oxyhaemoglobin. Subjects were fitted with an ambula-
tory blood pressure monitor (Spacelabs 90217; Spacelabs,
Healthcare Ltd, Hertford, UK) prior to each exposure and
monitored for 24 h.
Wood smoke exposure
Exposures were performed in a purpose-built exposure
chamber in Umeå, Sweden. During each exposure, sub-
jects performed moderate exercise (to generate an average
minute ventilation of 20 L/min/m2) on a bicycle ergom-
eter that was alternated with rest at 15-min intervals.
Wood smoke was generated using a common Nordic
wood stove using birch wood in an incomplete combus-
tion firing procedure (partial air-starved conditions),
generating a soot-rich aerosol emission. To generaterelatively constant incomplete combustion conditions
during the 1 hour exposures, small batches (0.5–1.0 kg)
birch wood logs were inserted every 5–15 minutes to
maintain a high burn rate with repeated air-starved con-
ditions. This procedure was in accordance with our pre-
vious wood smoke exposure study [14]. The birch wood
was stored outdoors under roof cover for approxi-
mately 2.5 years before use and had a moisture content of
16–17% at the time of this study. The wood smoke was
diluted with HEPA filtered air in three steps and con-
tinuously fed into and through a controlled environ-
ment exposure chamber (17 m3) to achieve a steady state
concentration.
The atmosphere in the chamber was monitored for
pollutants using continuous measurement of oxides
of nitrogen (NOx) (chemiluminescence, CLD 700
Ecophysics, >0.001 ppm) and carbon monoxide (CO)
(IR, UNOR6N Maihak). Fine (<1 μm) particulate matter
(PM1) mass concentration was measured on-line using a
tapered element oscillating microbalance (TEOM 1400,
Thermo Scientific). Integrated with the TEOM a filter
(Teflon) sampling line was used to determine the mass
concentration gravimetrically. A CO alarm instrument
(MC400, Monicon Technology) was used in the chamber
during the exposures. The target PM1 concentration in
the chamber was 1,000 μg/m3.
The equivalent mobility diameter (in the range 10–
600 nm) of the wood smoke particles was measured in
the chamber using a scanning mobility particle sizer
(SMPS) (TSI GmbH). Organic (OC) and elemental car-
bon (EC) were determined using thermal-optical carbon
analysis (according to the EUSAAR_2 protocol). These
concentrations are regularly encountered at the perim-
eter of forest fires [50] and indoors when cooking with
solid fuels [51], and are below the UK workplace 8 hour
average exposure limits (HSE EH40 Workplace Exposure
Limits 2005). The temperature in the chamber main-
tained between 21–24°C with a relative humidity of 50%.
Polycyclic aromatic hydrocarbon analysis
The collected wood smoke PM, and polyurethane foam
(PUF) plugs with sampled semi-volatile PAHs were ex-
tracted with pressurized fluid extraction using an ASE 200
Accelerated Solvent Extractor system (Dionex Corporation,
Sunnyvale, CA, USA). Wood smoke PM was extracted with
a solvent composition consisting of toluene and methanol
9:1 at 200°C and 3000 psi (20.7 MPa). PUFs were extracted
with hexane at 110°C and 500 psi (3.45 MPa). Details on
instrumental parameters are available elsewhere [52,53].
Solid phase extraction sample cleanup was performed to
remove polar constituents from the samples according to
Christensen et al. [54] followed by instrumental analysis
using an automated high pressure liquid chromatography-
gas chromatography–mass spectrometry system (HPLC-
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PAH fraction using the back flush technique, where PAHs
with 3 and more rings were isolated and introduced into
the GC-MS system for separation and detection. The MS
was operated in selected ion monitoring mode, and the
PAHs were identified using compound specific mass to
charge ratio and relative retention time on the GC capil-
lary column. In total 36 PAHs in the range of 178 –
302 Da were analyzed (Additional file 1: Table S1).
Electron paramagnetic resonance
To provide a measure of particle reactivity EPR was used
to establish oxygen-centred free radical generation from
particulates collected from exposures (Langrish et al.
[7]). A 1.6 mm diameter section of Teflon filter from the
carbon analysis filter line of the exposure chamber and
suspended in physiological saline solution (Krebs buffer,
composition in mM: 118.4 NaCl, 25 NaHCO3, 11 glu-
cose, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 2.5 CaCl2) at a
particle concentration of 100 μg/mL. Samples were vor-
texed for 1 min, followed by 30 min sonication sonication
(100% power; Fisherbrand FB11002; Fisher Scientific,
Loughborough, UK). Suspensions were incubated with
the spin-trap, Tempone-H (1 mM; Enzo Life Sciences,
Exeter, UK), immediately before the initial measurement.
Tempone-H is a highly sensitive spin-trap that shows se-
lectivity for superoxide, forming a stable product that can
be measured by EPR [55]. The standard reference material
urban dust (SRM1649a; National Institute of Standards
and Technology, Gaithersburg, USA) was used as positive
control particulate (note, that the results cannot be dir-
ectly compared to filter particulates, as the proportion of
the mass of wood smoke particulate unbound to the filter
cannot be determined in the present study). Pyrogallol
(100 μM) was used as a second positive control which
spontaneously generates superoxide radicals in this buffer
[56]. Samples were kept at 37°C throughout and measure-
ments were taken after 30 and 60 min by drawing 50 μL
of sample into a capillary tube (VWR International,
Lutterworth, UK) and sealing with a plug of soft sealant
(Cristaseal, VWR International). An X-band EPR spec-
trometer (Magnettech MS-200, Berlin, Germany) was
used with the following parameters: microwave frequency,
9.3–9.55 Hz; microwave power, 20 mW; modulation fre-
quency, 100 kHz; modulation amplitude, 1500 mG; center
field, 3365 G; sweep width, 50 G; sweep time, 30 s; num-
ber of passes, 1. Baseline signals from blank (non-exposed)
filters were subtracted from that of filters with particulate.
Arterial stiffness
All measurements of arterial stiffness were performed at
baseline, and at 10-min intervals after the exposure for
one hour as previously described [14]. Pulse rate and
blood pressure were measured using a validated semi-automated oscillometric sphygmomanometer (Boso-Medicus,
Boso, Jungingen, Germany). Central arterial stiffness mea-
sured by pulse wave analysis was determined with a high-
fidelity handheld tonometer (Millar Instruments, Texas,
USA) at the right radial artery using the SphygmoCor™
system (AtCor Medical, Sydney, Australia). Carotid-
femoral pulse wave velocity measurements were made
using the Vicorder system (Skidmore Medical, UK).
Vascular studies
All subjects underwent brachial artery cannulation with
a 27-standard wire gauge steel needle under controlled
conditions. After a 30-min saline infusion, acetylcholine
at 5, 10, and 20 μg/min (endothelium-dependent vaso-
dilator that does not release tissue plasminogen activator
[t-PA]; Merck Biosciences); bradykinin at 100, 300, and
1000 pmol/min (endothelium-dependent vasodilator that
releases t-PA; Merck Biosciences); sodium nitroprusside
at 2, 4, and 8 μg/min (endothelium-independent vasodila-
tor that does not release t-PA; David Bull Laboratories)
and verapamil at 10, 30, and 100 μg/min (endothelium-
and NO-independent vasodilator that does not release
t-PA) were infused for 6 min at each dose. Vasodila-
tors were separated by 20-min saline infusions and given
in a randomized order except from verapamil, which was
always given last due to its longer duration of action [57].
Forearm blood flow was measured in infused and non-
infused arms by venous occlusion plethysmography with a
mercury-in-silicone elastomer strain gauges as described
previously [58].
Venous cannulas (17 gauge) were inserted into large
subcutaneous veins of the ante-cubital fossae of both
arms. Blood (10 mL) was withdrawn simultaneously from
each arm at baseline and during infusion of each dose of
bradykinin and collected into acidified buffered citrate
(Stabilyte tubes, Biopool International). Samples were kept
on ice before being centrifuged at 2000 g for 30 min
at 4°C. Platelet-free plasma was decanted and stored
at −80°C before assay. Plasma t-PA antigen and activ-
ity concentrations were determined by enzyme-linked
immunosorbant assay (TECHNOZYM® t-PA Combi
Actibind®, Technoclone, Austria). Hematocrit was de-
termined by capillary tube centrifugation at baseline
and during infusion of bradykinin at 1000 pmol/min.
Flow cytometry
Samples were obtained at baseline, at 2 h immediately
prior to the thrombosis study and at 24 h post exposure,
and processed according to previously described proto-
cols [59]. In brief, blood was taken from an ante-cubital
vein using a 21-gauge cannula and anti-coagulated with
D-phenylalanyl-Lprolyl-L-arginine chloromethylketone
(75 μL; Cambridge Biosciences, UK). Samples were not ana-
lysed unless venesection achieved rapid and uninterrupted
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were stained with the following conjugated monoclonal
antibodies: phycoerythrin (PE)-conjugated CD14 (Dako,
Denmark), PE-conjugated CD62P, and PE-conjugated
CD154 (Becton-Dickinson, UK); PE-conjugated CD40,
fluorescein isothiocyanate (FITC)-conjugated CD42a, and
FITC-conjugated CD14 (Serotec, USA); and appropri-
ate control isotypes. All antibodies were diluted 1:20.
Once stained, samples were incubated for 20 min at
room temperature to identify P-selectin and CD40L on
the platelet surface and CD40 on the monocyte surface.
Platelet–monocyte samples were fixed with FACS-Lyse
(Becton-Dickinson). Platelet samples were fixed with 1%
paraformaldehyde. Samples were analysed within 24 h
using a FACScan flow cytometer (Becton-Dickinson).
Platelet–monocyte aggregates were defined as monocytes
positive for CD14. Data analysis was performed using
FlowJo (Treestar, USA).
Ex-vivo thrombosis studies
Thrombus formation was measured using the Badimon
chamber as previously described [13,23]. In brief, a pump
was used to draw blood from an antecubital vein through a
series of consecutive cylindrical perfusion chambers main-
tained at 37°C in a water bath. Carefully prepared strips of
porcine aorta, from which the intima and a thin layer of
media had been removed, acted as the thrombogenic sub-
strate. Each study lasted for 5 min during which flow was
maintained at a constant rate of 10 mL/min. Porcine strips
with thrombus attached were removed and fixed in 4%
paraformaldehyde, wax embedded, sectioned, and stained
with Masson’s Trichrome. Images were acquired at × 20
magnification, and the thrombus area was measured using
an Ariol image acquisition system (Leica Microsystems
GmbH, Germany) by a blinded operator. Results from at
least six sections were averaged to determine thrombus
area for each chamber, as described previously [13,23].
Data analysis and statistics
A sample size of 16 gives us >90% power to detect a 10%
difference in thrombus area, 17% difference in mean t-PA
release and 22% difference in forearm blood flow at a sig-
nificance level of 5% [12,47-49]. Continuous variables are
reported as mean ± standard error of the mean (SEM).
Statistical analyses were performed with GraphPad Prism,
version 5.0 (Graph Pad Software, USA) by 2-way analysis
of variance (ANOVA) with repeated measures and 2-tailed
Student t-test, where appropriate. Statistical significance
was taken at two-sided P < 0.05.
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